Humoral immune response to hypervariable region 1 of a hepatitis C viral envelope glycoprotein (gp70) obtained from an asymptomatic carrier
スポンサーリンク
概要
著者
-
KATO Nobuyuki
Virology Division, National Cancer Center Research Institute
-
Fujioka Takahiro
Gastroenterology Division Of Internal Medicine School Of Medicine Kitasato University
-
Shimotohno Kunitada
Virology Division National Cancer Center Research Institute
-
Shimotohno Kunitada
Virology Division National Cancer Center Research Institule
-
SHIBUYA Akitaka
Gastroenterology Division of Internal Medicine, Kitasato University East Hospital
-
NAKAZAWA Takahide
Virology Division, National Cancer Center Research Institule
-
Shibuya Akitaka
Gastroenterology Division Of Internal Medicine School Of Medicine Kitasato University
-
Nakazawa Takahide
Virology Division National Cancer Center Research Institule
-
Kato Nobuyuki
Virology Division National Cancer Center Research Institule
関連論文
- New Monoclonal Antibodies against a Recombinant Second Envelope Protein of Hepatitis C Virus
- Hepatitis C Virus NS5B RNA Replicase Specifically Binds Ribosomes
- Lactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot Study
- Hepatitis C Virus in Pelvic Lymph Nodes and Female Reproductive Organs
- Replication of Hepatitis C Virus in Cultured Non-neoplastic Human Hepatocytes
- New angiotensin II type 1 receptor blocker olmesartan improves portal hypertension in patients with cirrhosis
- Single-Step Reverse Transcription-Polymerase Chain Reaction for the Detection of Hepatitis C Virus RNA
- HEPATITIS C VIRUS AND HEPATOCELLULAR CARCINOMA
- Humoral immune response to hypervariable region 1 of a hepatitis C viral envelope glycoprotein (gp70) obtained from an asymptomatic carrier
- Chemical Modification of Cytosine Residues of tRNA^ with Hydrogen Sulfide (Nucleosides and Nucleotides. XL)
- Screening of Some Indonesian Medicinal Plants for Inhibitory Effects on HIV-1 Protease
- Japanese isolates of the non-A, non-B hepatitis viral genome show sequence variations from the original isolate in the U.S.A.
- Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib